Atossa Genetics Announces Institutional Review Board Approval of Oral Endoxifen as Post-Mastectomy Treatment for a U.S. Breast Cancer Patient

Stock Information for Atossa Genetics Inc.

Loading

Please wait while we load your information from QuoteMedia.